» Articles » PMID: 17493199

Alternative Definitions of Sarcopenia, Lower Extremity Performance, and Functional Impairment with Aging in Older Men and Women

Overview
Specialty Geriatrics
Date 2007 May 12
PMID 17493199
Citations 338
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To compare two methods for classifying an individual as sarcopenic for predicting decline in physical function in the Health, Aging and Body Composition Study.

Design: Observational cohort study with 5 years of follow-up.

Setting: Communities in Memphis, Tennessee, and Pittsburgh, Pennsylvania.

Participants: Men and women aged 70 to 79 (N=2,976, 52% women, 41% black).

Measurements: Appendicular lean mass (aLM) was measured using dual energy x-ray absorptiometry, and participants were classified as sarcopenic first using aLM divided by height squared and then using aLM adjusted for height and body fat mass (residuals). Incidence of persistent lower extremity limitation (PLL) was measured according to self-report, and change in objective lower extremity performance (LEP) measures were observed using the Short Physical Performance Battery.

Results: There was a greater risk of incident PLL in women who were sarcopenic using the residuals sarcopenia method than in women who were not sarcopenic (hazard ratio (HR)=1.34, 95% confidence interval (CI)=1.11-1.61) but not in men. Those defined as sarcopenic using the aLM/ht(2) method had lower incident PLL than nonsarcopenic men (HR=0.76, 95% CI=0.60-0.96) and women (HR=0.75, 95% CI=0.60-0.93), but these were no longer significant with adjustment for body fat mass. Using the residuals method, there were significantly poorer LEP scores in sarcopenic men and women at baseline and Year 6 and greater 5-year decline, whereas sarcopenic men defined using the aLM/ht(2) method had lower 5-year decline. Additional adjustment for fat mass attenuated this protective effect.

Conclusion: These findings suggest that sarcopenia defined using the residuals method, a method that considers height and fat mass together, is better for predicting disability in an individual than the aLM/ht(2) method, because it considers fat as part of the definition.

Citing Articles

A prediction model for the risk of developing mild cognitive impairment in older adults with sarcopenia: evidence from the CHARLS.

Liu X, Ni J, Wang B, Yin R, Tang J, Chu Q Aging Clin Exp Res. 2025; 37(1):69.

PMID: 40055290 PMC: 11889009. DOI: 10.1007/s40520-025-02980-2.


Relationship between estimated pulse wave velocity and the risk of future sarcopenia in middle-aged and older Chinese adults: evidence from the China Health and Retirement Longitudinal Study.

Song D, Miao J, Zhang Y, Zhu A Front Cardiovasc Med. 2025; 12:1494635.

PMID: 40034988 PMC: 11872886. DOI: 10.3389/fcvm.2025.1494635.


Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions.

Wang T, Zhou D, Hong Z MedComm (2020). 2025; 6(1):e70030.

PMID: 39764565 PMC: 11702502. DOI: 10.1002/mco2.70030.


Significance of the modified global leadership initiative on malnutrition (GLIM) criteria malcondition for patients with biliary tract cancer.

Igarashi T, Harimoto N, Fukushima R, Hagiwara K, Hoshino K, Kawai S Surg Today. 2024; .

PMID: 39623193 DOI: 10.1007/s00595-024-02970-3.


Sex differences in the association between sarcopenia index and sarcopenia: a cross-sectional study from a Chinese community-based population.

Yang H, Huang Y, Jiang G, Duan Z, Du R, Hao Y Eur Geriatr Med. 2024; 16(1):55-65.

PMID: 39623162 PMC: 11850426. DOI: 10.1007/s41999-024-01111-w.